Almost a third of women with low-grade serous ovarian cancer, which does not respond well to chemotherapy, saw their tumours shrink or stop growing with the drugs Almost a third of women with low-grade serous ovarian cancer, which does not respond well to chemotherapy, saw their tumours shrink or stop growing with the drugs
Hope for women with rare ovarian cancer as new drug combo is shown to shrink tumours
